Literature DB >> 32921733

Vaccine hesitancy in COVID-19 times. An update from Italy before flu season starts.

Anna Odone1, Daria Bucci2, Roberto Croci3, Matteo Riccò4, Paola Affanni5, Carlo Signorelli6.   

Abstract

The COVID-19 pandemic and response caused a worrying decline in vaccine uptake around the world. In Italy, the immunization coverage targets set in the 2017-19 National Immunization Prevention Plan (PNPV) have been met only partially. The current public health emergency is likely to have negatively impacted on immunization , with the risk of re-occurrence of Vaccine-Preventable Diseases (VPDs) outbreaks. As flu season approaches, both National Health Institutions  and the scientific community in Italy have taken action. Well in advance as compared to previous years, the Ministry of Health released  the Circular to launch the 2020-2021 influenza immunization campaign which this year is longer (starting on October 2020) and extends flu vaccine recommendations to more  "at risk" subgroups, offered the vaccine free of charge. In addition, some Italian Regions have recently tried to make  flu vaccination compulsory for all Healthcare Workers (HCWs). Since 2017, when the law on childhood vaccination in Italy was passed, compulsory vaccination has proved to be a successful strategy towards coverage increase.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32921733      PMCID: PMC7716975          DOI: 10.23750/abm.v91i3.10549

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


The COVID-19 pandemic (caused by the SARS-CoV-2 virus) has disrupted routine immunization services worldwide. This has contributed to decreased immunization uptake at all age s (1–4), making vaccine hesitancy relevant again. In the period 2010-2014, alarming reductions in vaccine coverage were reported in Italy – a country with a strong tradition of public immunization policies (5,6). In more recent times, both national and regional authorities, jointly withthe scientific community have tried to counter this phenomenon by deploying new strategies, such as approving a novel, evidence-based National Immunization Prevention Plan (PNPV) 2017–19, mobilizing key stakeholders and issuing a new Law (n. 119/2017) which extended the number of mandatory vaccinations from four to ten (7–9). Reflecting on previous challenges, successes and lessons learned can be of great benefit when entering a new flu season in COVID-19 pandemic times. When assessing the impact of the 2017-2019 PNPV in Italy, there are both positive and negative aspects: on the one hand, national-level trends in childhood immunization coverage reached (and in some cases exceeded) set coverage targets (10). In addition, since the law was approved, increased coverage has been also reported for some non-compulsory childhood vaccinations, including Meningococcal B (2016 coverage: 15%; 2018 coverage: 46%), and Pneumococcal Conjugate (2016 coverage: 88%; 2018 coverage: 92%)vaccines. On the other hand, we must acknowledge the failure in not reaching coverage targets for other vaccines, including Rotavirus (11,12), Varicella-Zoster Virus and Pneumococcal vaccine in older adults. Even more worrying are declining coverage rates in adolescents (13): Human Papilloma Virus (HPV) vaccine coverage declined from 53% in 2016 to 40% in 2018 in 12-year old girls, and did not exceed 20% coverage in 12- year old boys (2016 data are not available). Similarly, 2018 Meningococcal ACWY vaccine coverage was less than 30% in 18-year old adolescents. As for the influenza vaccine, coverage rates in the elderly (i.e. ≥ 65 years old) have not yet reached the pre- “Fluad episode” 2014 levels (15,16), while coverage in HCWs, despite all the efforts remains below 20% (14,17,18). This was the pre-COVID picture in Italy. During the COVID-19 pandemic, both vaccine supply and demand decreased. Indeed, the provision of immunization services was discontinued, scheduled vaccinations were postponed due to the containment measures in place (19,20) and the fear of contagion within the general population decreased access to immunization clinics. On July 15th, 2020, the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO) warned of a decline in childhood vaccinations during COVID-19 (21). According to the preliminary results of a currently ongoing WHO-sponsored international survey, overall immunization coverage has declined in 85% of the 82 respondent countries. As for Italy, informal data released by Local Health Authorities (Aziende Sanitarie Locali, ASL) confirm a relevant drop in immunization coverage rates. For example, Rome’s main ASL reported a 16% decrease in the number of administered vaccine doses during the 10 weeks of strict lockdown (22). If, on one side, COVID-19 highlighted the instability related to infectious diseases spread, on the other hand the road to recovery will be an uphill one. The Italian Society of Pediatrics carried out a survey among 1500 parents, revealing that over 33% of them postponed scheduled vaccinations for their children due to fear of COVID-19. Despite the strong call coming from the Scientific Board of the “Lifetime Immunization Schedule” (23) (jointly supported by the Italian Public Health, Pediatrics and General Medicine scientific societies, SItI, SIP, FIMMG, and FIMP) with the slogan: “let’s avoid adding epidemics to the pandemic”, the situation remains challenging. The first testing ground will be the upcoming 2020- 21 flu season. The Ministry of Health yearly Circular document (24) was released in June 2020, well in advance ascompared to previous seasons. The Circular introduced substantial changes and updated vaccine indications (Table 2). It extended the window period of the campaign starting from the beginning of October, recommended free seasonal flu vaccination to all subjects aged 60 through 64 (adding to the over-65 target population), and also to children from 6 months to 6 years of age, as well as to HCWs. The scientific rationale behind these new measures lies in the fact that influenza and SARS-CoV-2 infections will likely co-circulate in winter. Therefore, reaching high flu vaccine coverage will not only mitigate the disease-specific burden, but also ease the differential diagnosis of suspect COVID-19 cases.
Table 2.

Changes introduced in the Ministerial Circular Letter for the Flu Vaccination Campaign 2020-21

Source: Directorate General of Health Prevention, Italian Ministry of Health

Italian Ministry of Health, Circular Letter for the Flu Vaccination Campaign 2020-21

Extending the campaign: from October through the end of the season

Offering free vaccination to all subjects over 60

Offering free vaccination to all children from 6 months to 6 years old

For health care workers (HCWs), social workers and institutionalized individuals, vaccination against influenza is “strongly

Italian national-level immunization coverage rates, by target and year. Source, Italian Ministry of Health (24–30) and WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) (31) Changes introduced in the Ministerial Circular Letter for the Flu Vaccination Campaign 2020-21 Source: Directorate General of Health Prevention, Italian Ministry of Health Extending the campaign: from October through the end of the season Offering free vaccination to all subjects over 60 Offering free vaccination to all children from 6 months to 6 years old For health care workers (HCWs), social workers and institutionalized individuals, vaccination against influenza is “strongly In this scenario, two regions (Lazio and Campa- nia) introduced flu mandatory vaccination for HCWs and for those aged ≥ 65 years. Despite some criticisms and opposition, this has paved the way for a “conscious obligation”, supported by a renewed trust in public health action. Still, if one side, there is public consensus on the need to promote responsible and informed adoption of preventive behaviors, including immunization, on the other hand it is equally true that in recent years the only effective intervention to increase vaccine uptake and population coverage has been the Law on compulsory vaccinations in children. The scientific public health community has to acknowledge this evidence and to start building its future mission from there.
Table 1.

Italian national-level immunization coverage rates, by target and year. Source, Italian Ministry of Health (24–30) and WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) (31)

  21 in total

1.  When vaccine hesitancy makes headlines.

Authors:  A Odone; C Signorelli
Journal:  Vaccine       Date:  2015-12-02       Impact factor: 3.641

2.  Childhood vaccine coverage in Italy after the new law on mandatory immunization.

Authors:  C Signorelli; A Odone; P Cella; S Iannazzo
Journal:  Ann Ig       Date:  2018 Jul-Aug

Review 3.  Vaccines and routine immunization strategies during the COVID-19 pandemic.

Authors:  Ener Cagri Dinleyici; Ray Borrow; Marco Aurélio Palazzi Safadi; Pierre van Damme; Flor M Munoz
Journal:  Hum Vaccin Immunother       Date:  2020-08-26       Impact factor: 3.452

4.  The 2016 Lifetime Immunization Schedule, approved by the Italian scientific societies: A new paradigm to promote vaccination at all ages.

Authors:  Paolo Bonanni; Giampietro Chiamenti; Giorgio Conforti; Tommasa Maio; Anna Odone; Rocco Russo; Silvestro Scotti; Carlo Signorelli; Alberto Villani
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

5.  Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study.

Authors:  Timothy Roberton; Emily D Carter; Victoria B Chou; Angela R Stegmuller; Bianca D Jackson; Yvonne Tam; Talata Sawadogo-Lewis; Neff Walker
Journal:  Lancet Glob Health       Date:  2020-05-12       Impact factor: 26.763

6.  Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.

Authors:  Kaja Abbas; Simon R Procter; Kevin van Zandvoort; Andrew Clark; Sebastian Funk; Tewodaj Mengistu; Dan Hogan; Emily Dansereau; Mark Jit; Stefan Flasche
Journal:  Lancet Glob Health       Date:  2020-07-17       Impact factor: 26.763

7.  Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.

Authors:  Andrew Clark; Mark Jit; Charlotte Warren-Gash; Bruce Guthrie; Harry H X Wang; Stewart W Mercer; Colin Sanderson; Martin McKee; Christopher Troeger; Kanyin L Ong; Francesco Checchi; Pablo Perel; Sarah Joseph; Hamish P Gibbs; Amitava Banerjee; Rosalind M Eggo
Journal:  Lancet Glob Health       Date:  2020-06-15       Impact factor: 26.763

8.  COVID-19 mortality rate in nine high-income metropolitan regions.

Authors:  Carlo Signorelli; Anna Odone; Vincenza Gianfredi; Eleonora Bossi; Daria Bucci; Aurea Oradini-Alacreu; Beatrice Frascella; Michele Capraro; Federica Chiappa; Lorenzo Blandi; Fabio Ciceri
Journal:  Acta Biomed       Date:  2020-07-20

9.  Knowledge, attitudes, beliefs and practices of Occupational Physicians towards seasonal influenza vaccination: a cross-sectional study from North-Eastern Italy.

Authors:  M Riccò; S Cattani; F Casagranda; G Gualerzi; C Signorelli
Journal:  J Prev Med Hyg       Date:  2017-06

10.  COVID-19 deaths in Lombardy, Italy: data in context.

Authors:  Anna Odone; Davide Delmonte; Thea Scognamiglio; Carlo Signorelli
Journal:  Lancet Public Health       Date:  2020-04-25
View more
  15 in total

1.  Improving knowledge, attitudes and practice to prevent COVID-19 transmission in healthcare workers and the public in Thailand.

Authors:  Rapeephan R Maude; Monnaphat Jongdeepaisal; Sumawadee Skuntaniyom; Thanomvong Muntajit; Stuart D Blacksell; Worarat Khuenpetch; Wirichada Pan-Ngum; Keetakarn Taleangkaphan; Kumtorn Malathum; Richard James Maude
Journal:  BMC Public Health       Date:  2021-04-18       Impact factor: 3.295

Review 2.  Evolving measles status and immunization policy development in six European countries.

Authors:  Ivo Vojtek; Heidi Larson; Stanley Plotkin; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2022-02-18       Impact factor: 4.526

3.  Shifting the Paradigm: The Dress-COV Telegram Bot as a Tool for Participatory Medicine.

Authors:  Michela Franchini; Stefania Pieroni; Nicola Martini; Andrea Ripoli; Dante Chiappino; Francesca Denoth; Michael Norman Liebman; Sabrina Molinaro; Daniele Della Latta
Journal:  Int J Environ Res Public Health       Date:  2020-11-26       Impact factor: 3.390

4.  Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?

Authors:  Salvatore Chirumbolo
Journal:  J Med Virol       Date:  2021-03-25       Impact factor: 20.693

Review 5.  Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.

Authors:  Jiří Beran; Marián Špajdel; Jiří Slíva
Journal:  Viruses       Date:  2021-11-09       Impact factor: 5.048

6.  Impact of COVID-19 pandemic on routine immunization.

Authors:  Martin O C Ota; Selim Badur; Luis Romano-Mazzotti; Leonard R Friedland
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

7.  Virological surveillance of SARS-CoV-2 in an Italian Northern area: differences in gender, age and Real Time RT PCR cycle threshold (Ct) values in three epidemic periods.

Authors:  Mostafa Mohieldin Mahgoub Ibrahim; Maria Eugenia Colucci; Licia Veronesi; Isabella Viani; Anna Odone; Mattia Pia Arena; Monia Incerti; Elisa Tamburini; Roberta Zoni; Cesira Pasquarella; Paola Affanni
Journal:  Acta Biomed       Date:  2021-10-07

Review 8.  Challenges and Opportunities of Mass Vaccination Centers in COVID-19 Times: A Rapid Review of Literature.

Authors:  Vincenza Gianfredi; Flavia Pennisi; Alessandra Lume; Giovanni Emanuele Ricciardi; Massimo Minerva; Matteo Riccò; Anna Odone; Carlo Signorelli
Journal:  Vaccines (Basel)       Date:  2021-06-01

9.  Intention to Be Vaccinated for COVID-19 among Italian Nurses during the Pandemic.

Authors:  Marco Trabucco Aurilio; Francesco Saverio Mennini; Simone Gazzillo; Laura Massini; Matteo Bolcato; Alessandro Feola; Cristiana Ferrari; Luca Coppeta
Journal:  Vaccines (Basel)       Date:  2021-05-12

10.  Childhood Immunisation Coverage during the COVID-19 Epidemic in Italy.

Authors:  Michela Sabbatucci; Anna Odone; Carlo Signorelli; Andrea Siddu; Andrea Silenzi; Francesco Paolo Maraglino; Giovanni Rezza
Journal:  Vaccines (Basel)       Date:  2022-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.